We are a leading healthcare campus encompassing all fields of health: from healthcare and research to teaching and management.
Professionalism, commitment and research by professionals on the Campus are the key elements in offering patients excellent care.
We are committed to research as a tool to provide solutions to the daily challenges we face in the field of medical healthcare.
Thanks to our healthcare, teaching and research potential, we work to incorporate new knowledge to generate value for patients, professionals and the organization itself.
We generate, transform and transmit knowledge in all areas of the health sciences, helping to train the professionals of the future.
We are defined by our vocation for communication. We invite you to share everything that happens at Vall d'Hebron Barcelona Hospital Campus, and our doors are always open.
Hospital donations
Research donations
Speaker: Dr. Ignacio Ochoa Garrido, Head of the Tissue Microenvironment Laboratory (TMB LAB) of the Health Research Institute of Aragon (IIS ARAGON).
Dr. Ignacio Ochoa obtained his Bachelor's degree in Biology and Biochemistry from the University of Navarra in 1999 and 2003. He completed his Ph.D. in the Department of Histology and Pathology of this same university in 2004. After this stage, he joined the group of Structural Mechanics and Modeling of Materials (GEMM) of the University of Zaragoza to carry out his postdoctoral stay and start up the group's experimental bio-laboratory. Dr. Ochoa studied how the environment conditioned cellular behavior at the micro (microfluidics) and macroscale (tissue engineering) during this period. In 2015, he started as an assistant professor in the Department of Human Anatomy and Histology at the Faculty of Medicine of the University of Zaragoza, where he is actually an associate professor. He is the principal investigator of the Tissue Microenvironment (TME) research group of Aragon Institute of Engineering Research (I3A) and the CIBER BBN. This research group also belongs to the Institute for Health Research Aragon - IIS Aragón. Dr.Ochoa is also coordinator of the "new technologies and innovation applied to health” program in this health research institute. Dr. Ochoa has published more than 50 articles in indexed international journals, four book chapters, and mora than 10 patents, 5 of them licensed. Also, he has been an invited speaker in several national and international meetings and conferences. Dr. Ochoa is also co-founder of BEONCHIP SL, a company dedicated to developing and commercializing microfluidic devices for organ-on-chip applications, and founding partner of "EBERS SL," a company dedicated to the development and commercialization of equipment for tissue engineering.
Abstract: Glioblastoma, a highly heterogeneous tumor, exhibits not only spatial variation but also temporal diversity. Replicating such intricate tumor characteristics in vitro has posed challenges with conventional cell culture methods. Nonetheless, the emergence of microfluidics in cell cultivation has provided a gateway to recreating intricate microenvironments. This study successfully emulates pivotal features of these lethal brain tumors by harnessing microphysiological systems, also known as organ-on-chip devices. Through smart implementation of these platforms, we replicate responses to treatments across diverse environmental conditions, model pseudo-palisading formations, simulate necrotic cores, and explore their impact on immune responses. Our findings underscore the pivotal role of the tumor microenvironment, revealing its capacity to shape cellular behavior and treatment responsiveness. This insight advocates for the integration of such microenvironmental considerations into preclinical models, trying to enhance predictive accuracy for clinical treatment responses. Moreover, these models illuminate the interplay between tumor and non-tumor cells, elucidating their adaptive behavior in varying environments and offering avenues for identifying novel therapeutic targets and biomarkers.
Host: Dr. Ibane Abasolo Olaortua, Head of group Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT).
Online registration: https://gencat.zoom.us/webinar/register/WN_TEeCubtyT927ZurFqqR0Tw
The acceptance of these terms implies that you give your consent to the processing of your personal data for the provision of the services you request through this portal and, if applicable, to carry out the necessary procedures with the administrations or public entities involved in the processing. You may exercise the mentioned rights by writing to web@vallhebron.cat, clearly indicating in the subject line “Exercise of LOPD rights”. Responsible entity: Vall d’Hebron University Hospital (Catalan Institute of Health). Purpose: Subscription to the Vall d’Hebron Barcelona Hospital Campus newsletter, where you will receive news, activities, and relevant information. Legal basis: Consent of the data subject. Data sharing: If applicable, with VHIR. No other data transfers are foreseen. No international transfer of personal data is foreseen. Rights: Access, rectification, deletion, and data portability, as well as restriction and objection to its processing. The user may revoke their consent at any time. Source: The data subject. Additional information: Additional information can be found at https://hospital.vallhebron.com/es/politica-de-proteccion-de-datos.